Digital Pathology and AI for Liver Outcomes in MASLD

Clinical trial NCT06344364 · COMPLETED

Trial details

NCT number: NCT06344364
Sponsor: PharmaNest, Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Metabolic Dysfunction-associated Steatotic Liver Disease

Start date: 2025-09-01
Primary completion: 2026-03-01
Enrollment: 1241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.